NeuBase Therapeutics, Inc. Stock Split Ratio
NeuBase Therapeutics, Inc. had Stock Split Ratio of 5.00% as of 2023-06-14, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-11-09
- NeuBase Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2014 was 300.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2023-06-14 | 5.00% 10-Q · filed 2023-11-09 | |||
| 2019-01-18 | 5.00% 10-K · filed 2020-12-23 | |||
| 2014-09-30 | 300.00% 10-K · filed 2014-12-22 | |||
| 2013-06-30 | 300.00% 10-Q · filed 2013-08-13 | |||
| 2013-06-03 | 33.30% 10-K · filed 2013-12-27 |